SAB Biotherapeutics, Inc. (SABS) Free Cash Flow
SAB Biotherapeutics, Inc. (SABS) free cash flow history and trends. Track FCF in Excel with MarketXLS.
Free Cash Flow Data
| Period | Free Cash Flow (USD) |
|---|---|
| 2020-12-31 | -$2.72M |
| 2021-12-31 | -$8.96M |
| 2022-12-31 | -$25.63M |
| 2023-12-31 | -$25.32M |
| 2024-12-31 | -$34.63M |
| 2025-12-31 | -$45.71M |
How SABS compares with sector peers
| Symbol | Company | Free cash flow (latest fiscal year) |
|---|---|---|
| AVXL | Anavex Life Sciences Corp. | -$39.04M |
| RLMD | Relmada Therapeutics Inc. | -$45.79M |
| ACHV | Achieve Life Sciences Inc. | -$49.47M |
| AQST | Aquestive Therapeutics Inc. | -$52.99M |
| OSUR | OraSure Technologies Inc. | -$53.22M |
These are five companies in the same sector as SABS with a comparable annual free cash flow. Each figure above is that company's most recent completed fiscal year, read from the same annual statements as the table on its own page, so the period end dates can differ between rows.
Get SAB Biotherapeutics, Inc. Data in Excel
Stream real-time stock prices and financials directly into your spreadsheets with MarketXLS.
Try: =hf_Free_Cash_Flow("SABS", 2025, "")
| A | B | C | D | |
|---|---|---|---|---|
| 1 | Symbol | Price | Change | Volume |
| 2 | SABS | $2.98 | +3.11% | 0.66M |
| 3 | ||||
| 4 | ||||
| 5 |